These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 31718901

  • 1. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Steigerwald R, Brake DA, Barrera J, Schutta CJ, Kalla M, Wennier ST, Volkmann A, Hurtle W, Clark BA, Zurita M, Pisano M, Kamicker BJ, Puckette MC, Rasmussen MV, Neilan JG.
    Vaccine; 2020 Jan 22; 38(4):769-778. PubMed ID: 31718901
    [Abstract] [Full Text] [Related]

  • 2. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2018 Feb 14; 36(8):1078-1084. PubMed ID: 29358056
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
    Neilan JG, Schutta C, Barrera J, Pisano M, Zsak L, Hartwig E, Rasmussen MV, Kamicker BJ, Ettyreddy D, Brough DE, Butman BT, Brake DA.
    BMC Vet Res; 2018 Aug 29; 14(1):254. PubMed ID: 30157853
    [Abstract] [Full Text] [Related]

  • 4. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T, Kenney M, Barrera J, Pandya M, Eckstrom K, Warner M, Pacheco JM, LaRocco M, Palarea-Albaladejo J, Brake D, Rieder E, Arzt J, Barlow JW, Golde WT.
    Vaccine; 2019 Sep 30; 37(42):6221-6231. PubMed ID: 31493951
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP, Mohapatra JK, Pauszek SJ, Koster M, Dhanya VC, Tamil Selvan RP, Hosamani M, Saravanan P, Basagoudanavar SH, de Los Santos T, Venkataramanan R, Rodriguez LL, Grubman MJ.
    Vet Microbiol; 2017 May 30; 203():196-201. PubMed ID: 28619144
    [Abstract] [Full Text] [Related]

  • 6. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C, Barrera J, Pisano M, Zsak L, Grubman MJ, Mayr GA, Moraes MP, Kamicker BJ, Brake DA, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2016 Jun 08; 34(27):3214-3220. PubMed ID: 26707216
    [Abstract] [Full Text] [Related]

  • 7. Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.
    Puckette M, Clark BA, Smith JD, Turecek T, Martel E, Gabbert L, Pisano M, Hurtle W, Pacheco JM, Barrera J, Neilan JG, Rasmussen M.
    J Virol; 2017 Nov 15; 91(22):. PubMed ID: 28878081
    [Abstract] [Full Text] [Related]

  • 8. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J, Brake DA, Schutta C, Ettyreddy D, Kamicker BJ, Rasmussen MV, Bravo de Rueda C, Zurita M, Pisano M, Hurtle W, Brough DE, Butman BT, Harper BG, Neilan JG.
    Vaccine; 2018 Nov 19; 36(48):7345-7352. PubMed ID: 30327212
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN, Montiel N, Diaz-San Segundo F, Sturza D, Ramirez-Medina E, Grubman MJ, de los Santos T.
    Clin Vaccine Immunol; 2015 Nov 25; 23(2):125-36. PubMed ID: 26607309
    [Abstract] [Full Text] [Related]

  • 10. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR, Zhou X, Lefebvre DJ, Garnier A, Watier F, Pignon C, Lacour SA, Zientara S, Bakkali-Kassimi L, De Clercq K, Klonjkowski B.
    Vaccine; 2018 Apr 12; 36(16):2193-2198. PubMed ID: 29544690
    [Abstract] [Full Text] [Related]

  • 11. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M, Lohse L, Bøtner A, McInerney GM, Burman A, Jackson T, Polacek C, Belsham GJ.
    PLoS One; 2016 Apr 12; 11(6):e0157435. PubMed ID: 27294397
    [Abstract] [Full Text] [Related]

  • 12. Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.
    Barrera J, Brake DA, Kamicker BJ, Purcell C, Kaptur R, Schieber T, Lechtenberg K, Miller TD, Ettyreddy D, Brough DE, Butman BT, Colby M, Neilan JG.
    Transbound Emerg Dis; 2018 Apr 12; 65(2):447-455. PubMed ID: 29076657
    [Abstract] [Full Text] [Related]

  • 13. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ, Tian CJ, Zhu QS, Zhao MY, Xin AG, Nie WX, Ling SR, Zhu MW, Wu JY, Lan HY, Cao YC, Bi YZ.
    Vaccine; 2008 Mar 10; 26(11):1471-81. PubMed ID: 18289743
    [Abstract] [Full Text] [Related]

  • 14. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q, Moraes MP, Grubman MJ.
    Virus Res; 2003 Jun 10; 93(2):211-9. PubMed ID: 12782369
    [Abstract] [Full Text] [Related]

  • 15. A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease.
    Fowler V, Robinson L, Bankowski B, Cox S, Parida S, Lawlor C, Gibson D, O'Brien F, Ellefsen B, Hannaman D, Takamatsu HH, Barnett PV.
    Antiviral Res; 2012 Apr 10; 94(1):25-34. PubMed ID: 22330893
    [Abstract] [Full Text] [Related]

  • 16. Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine.
    Khalifa ME, El-Deeb AH, Zeidan SM, Hussein HA, Abu-El-Naga HI.
    Vet Microbiol; 2017 Oct 10; 210():1-7. PubMed ID: 29103677
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z, Pan L, Ding Y, Zhou P, Lv J, Chen H, Fang Y, Liu X, Chang H, Zhang J, Shao J, Lin T, Zhao F, Zhang Y, Wang Y.
    Appl Microbiol Biotechnol; 2015 Feb 10; 99(3):1389-98. PubMed ID: 25381487
    [Abstract] [Full Text] [Related]

  • 18. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec 10; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 19. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
    Brake DA, McIlhaney M, Miller T, Christianson K, Keene A, Lohnas G, Purcell C, Neilan J, Schutta C, Barrera J, Burrage T, Brough DE, Butman BT.
    Dev Biol (Basel); 2012 Dec 10; 134():123-33. PubMed ID: 22888605
    [Abstract] [Full Text] [Related]

  • 20. The Foot-and-Mouth Disease Carrier State Divergence in Cattle.
    Stenfeldt C, Eschbaumer M, Rekant SI, Pacheco JM, Smoliga GR, Hartwig EJ, Rodriguez LL, Arzt J.
    J Virol; 2016 Jul 15; 90(14):6344-64. PubMed ID: 27147736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.